A phase II study of Osimertinib for patients with radiotherapy-naïve CNS metastasis of non-small cell lung cancer: treatment rationale and protocol design of the OCEAN study (LOGIK 1603/WJOG 9116L).
Kazushige WakudaHiroyuki YamaguchiHirotsugu KenmotsuMinoru FukudaMasafumi TakeshitaTakayuki SuetsuguKeisuke KiritaNoriyuki EbiOsamu HatajiSatoru MiuraKenji ChibanaIsamu OkamotoKenichi YoshimuraKazuhiko NakagawaNobuyuki YamamotoKenji SugioPublished in: BMC cancer (2020)
UMIN identifier: UMIN000024218 (date of initial registration: 29 September 2016). jRCT identifier: jRCTs071180017 (date of initial registration: 13 February 2019).